161 related articles for article (PubMed ID: 3495540)
1. Antiproliferative effects of heparin on vascular smooth muscle cells are reversed by epidermal growth factor.
Reilly CF; Fritze LM; Rosenberg RD
J Cell Physiol; 1987 May; 131(2):149-57. PubMed ID: 3495540
[TBL] [Abstract][Full Text] [Related]
2. Heparin-like molecules regulate the number of epidermal growth factor receptors on vascular smooth muscle cells.
Reilly CF; Fritze LM; Rosenberg RD
J Cell Physiol; 1988 Jul; 136(1):23-32. PubMed ID: 3260902
[TBL] [Abstract][Full Text] [Related]
3. Growth regulation in primary culture of rabbit arterial smooth muscle cells by platelet-derived growth factor, insulin-like growth factor-I, and epidermal growth factor.
Yamamoto M; Yamamoto K
Exp Cell Res; 1994 May; 212(1):62-8. PubMed ID: 8174643
[TBL] [Abstract][Full Text] [Related]
4. Heparin inhibition of smooth muscle cell proliferation: a cellular site of action.
Reilly CF; Fritze LM; Rosenberg RD
J Cell Physiol; 1986 Oct; 129(1):11-9. PubMed ID: 3760032
[TBL] [Abstract][Full Text] [Related]
5. Rat vascular smooth muscle cells immortalized with SV40 large T antigen possess defined smooth muscle cell characteristics including growth inhibition by heparin.
Reilly CF
J Cell Physiol; 1990 Feb; 142(2):342-51. PubMed ID: 2154504
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells.
Pukac LA; Carter JE; Ottlinger ME; Karnovsky MJ
J Cell Physiol; 1997 Jul; 172(1):69-78. PubMed ID: 9207927
[TBL] [Abstract][Full Text] [Related]
7. The requirement of both intracellular reactive oxygen species and intracellular calcium elevation for the induction of heparin-binding EGF-like growth factor in vascular endothelial cells and smooth muscle cells.
Kayanoki Y; Higashiyama S; Suzuki K; Asahi M; Kawata S; Matsuzawa Y; Taniguchi N
Biochem Biophys Res Commun; 1999 May; 259(1):50-5. PubMed ID: 10334914
[TBL] [Abstract][Full Text] [Related]
8. Interaction of circulating cell-derived and plasma growth factors in stimulating cultured smooth muscle cell replication.
Clemmons DR
J Cell Physiol; 1984 Nov; 121(2):425-30. PubMed ID: 6386833
[TBL] [Abstract][Full Text] [Related]
9. Characterization of rat aortic smooth muscle cells resistant to the antiproliferative activity of heparin following long-term heparin treatment.
Bârzu T; Herbert JM; Desmoulière A; Carayon P; Pascal M
J Cell Physiol; 1994 Aug; 160(2):239-48. PubMed ID: 8040184
[TBL] [Abstract][Full Text] [Related]
10. Heparin-binding EGF-like growth factor expression increases selectively in bladder smooth muscle in response to lower urinary tract obstruction.
Borer JG; Park JM; Atala A; Nguyen HT; Adam RM; Retik AB; Freeman MR
Lab Invest; 1999 Nov; 79(11):1335-45. PubMed ID: 10576204
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of serum and transforming growth factor beta (TGF-beta1)-induced DNA synthesis in confluent airway smooth muscle by heparin.
Okona-Mensah KB; Shittu E; Page C; Costello J; Kilfeather SA
Br J Pharmacol; 1998 Oct; 125(4):599-606. PubMed ID: 9831891
[TBL] [Abstract][Full Text] [Related]
12. Regulation of insulin-like growth factor (IGF) binding protein-2 synthesis and degradation by platelet-derived growth factor and the IGFs is enhanced by serum deprivation in vascular smooth muscle cells.
Cohick WS; Gockerman A; Clemmons DR
J Cell Physiol; 1995 Jul; 164(1):187-96. PubMed ID: 7540619
[TBL] [Abstract][Full Text] [Related]
13. Entry and distribution of fluorescent antiproliferative heparin derivatives into rat vascular smooth muscle cells: comparison between heparin-sensitive and heparin-resistant cultures.
Bârzu T; Pascal M; Maman M; Roque C; Lafont F; Rousselet A
J Cell Physiol; 1996 Apr; 167(1):8-21. PubMed ID: 8698843
[TBL] [Abstract][Full Text] [Related]
14. Presence of epidermal growth factor receptors and influence of epidermal growth factor on proliferation and aging in cultured smooth muscle cells.
Bhargava G; Rifas L; Makman MH
J Cell Physiol; 1979 Aug; 100(2):365-74. PubMed ID: 315948
[TBL] [Abstract][Full Text] [Related]
15. Human uterine leiomyoma cells: binding and growth responses to epidermal growth factor, platelet-derived growth factor, and insulin.
Fayed YM; Tsibris JC; Langenberg PW; Robertson AL
Lab Invest; 1989 Jan; 60(1):30-7. PubMed ID: 2536127
[TBL] [Abstract][Full Text] [Related]
16. Vascular smooth muscle cells synthesize two forms of insulin-like growth factor binding proteins which are regulated differently by the insulin-like growth factors.
Cohick WS; Gockerman A; Clemmons DR
J Cell Physiol; 1993 Oct; 157(1):52-60. PubMed ID: 7691836
[TBL] [Abstract][Full Text] [Related]
17. Remnant lipoprotein-induced smooth muscle cell proliferation involves epidermal growth factor receptor transactivation.
Kawakami A; Tanaka A; Chiba T; Nakajima K; Shimokado K; Yoshida M
Circulation; 2003 Nov; 108(21):2679-88. PubMed ID: 14623816
[TBL] [Abstract][Full Text] [Related]
18. Altered cellular responses to serum mitogens, including platelet-derived growth factor, in cultured smooth muscle cells derived from arteries of patients with moyamoya disease.
Aoyagi M; Fukai N; Sakamoto H; Shinkai T; Matsushima Y; Yamamoto M; Yamamoto K
J Cell Physiol; 1991 May; 147(2):191-8. PubMed ID: 2040653
[TBL] [Abstract][Full Text] [Related]
19. L-iduronate-rich glycosaminoglycans inhibit growth of normal fibroblasts independently of serum or added growth factors.
Westergren-Thorsson G; Persson S; Isaksson A; Onnervik PO; Malmström A; Fransson LA
Exp Cell Res; 1993 May; 206(1):93-9. PubMed ID: 7683278
[TBL] [Abstract][Full Text] [Related]
20. Fucans, sulfated polysaccharides extracted from brown seaweeds, inhibit vascular smooth muscle cell proliferation. I. Comparison with heparin for antiproliferative activity, binding and internalization.
Logeart D; Prigent-Richard S; Jozefonvicz J; Letourneur D
Eur J Cell Biol; 1997 Dec; 74(4):376-84. PubMed ID: 9438134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
